Severe lung toxicity with a weekly low dose chemotherapy regimen in patients with non‐Hodgkin's lymphoma
- 1 October 1988
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 6 (4) , 319-324
- https://doi.org/10.1002/hon.2900060407
Abstract
Nineteen patients in poor prognostic subgroups of aggressive non‐Hodgkin's lymphoma (NHL) were treated with weekly chemotherapy consisting of low dose mitoxantrone and cyclophosphamide alternating with bleomycin and vincristine together with continuous oral prednisolone. Six patients developed pneumonitis which was severe in five patients. This occurred at total bleomycin doses of < 50 U/m2 and cyclophosphamide < 1875 mg/m2. The 31 per cent incidence of pneumonitis following low dose bleomycin suggests an increased susceptibility to drug‐induced pulmonary damage in non‐Hodgkin's lymphoma.Keywords
This publication has 18 references indexed in Scilit:
- Non-Hodgkin's lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patientsEuropean Journal of Cancer and Clinical Oncology, 1987
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- Pulmonary complications associated with combination chemotherapy programs containing bleomycinThe American Journal of Medicine, 1983
- Pulmonary Fibrosis after Prolonged Treatment with Low-Dose CyclophosphamideOncology, 1983
- Pulmonary complications of chemotherapy regimens containing bleomycinAmerican Journal of Roentgenology, 1982
- Reversibility of severe bleomycin-induced pneumonitisJAMA, 1978
- Reversibility of Severe Bleomycin-lnduced PneumonitisPublished by American Medical Association (AMA) ,1978
- Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, and Prednisone (BACOP) Combination Chemotherapy in the Treatment of Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1976
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973